Alamar Biosciences Statistics
NASDAQ: ALMRIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
26.11-1.66 (-5.98%)
Market open · Delayed 15 min · as of Oct 8, 3:55 PM ET
Alamar Biosciences by the numbers
Alamar Biosciences has a market capitalization of $1.81 billion based on 69.39M shares outstanding. With trailing EPS of $-1.20, Alamar Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.4% below its 50-day average and 2.2% below its 200-day average.
Average daily trading volume is 399.23K shares, or about $10.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ALMR valuation vs. peer median
| Metric | ALMR | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.81B | $245.31M | +639% |
| Avg. volume | 399.23K | 2.08M | -81% |
Peer median across 8 companies: PACB, CTKB, EYPT, LAB, NAUT, QTRX, SEER, CIRC.
Valuation
- Market cap
- $1.81B
- EPS (TTM)
- $-1.20
- Shares outstanding
- 69.39M
Price and trading
- Previous close
- 27.77
- Open
- 28.05
- Day range
- 25.39 – 28.07
- 52-week range
- 18.85 – 39.61
- Beta
- —
- Volume
- 842.74K
- Average volume
- 399.23K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 10, 2026
Additional statistics
- Market Cap
- 1.81B
- Forward Pe
- -48.13
- Eps
- -1.20
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 39.61
- Week52 Low
- 18.85
- Avg Volume
- 399.23K
- Shares Outstanding
- 69.39M
- Ma50
- 31.21
- Ma200
- 26.70
- Earnings Date
- Aug 10, 2026
- Pct From52w High
- -34.08%
- Pct From52w Low
- 38.51%